Literature DB >> 7767328

Corticosteroid feedback resistance in rats genetically selected for increased dopamine responsiveness.

N Y Rots1, A R Cools, J de Jong, E R De Kloet.   

Abstract

Pharmacogenetically selected Wistar rat lines were used to investigate the implication of either high or low responsiveness of the dopamine system for the activity of the hypothalamus-pituitary-adrenal (HPA) axis. As selection criterion the gnawing response induced by the dopamine agonist apomorphine was used. This criterion allows to distinguish apomorphine susceptible (apo-sus) rats which show a vigorous gnawing response from apomorphine unsusceptible (apo-unsus) rats. The present study, using male animals of the 9-12th generation of the two rat lines, revealed the following characteristics of the stress response system: (i) in apo-sus rats under basal conditions corticotrophin-releasing hormone (CRH) mRNA level in the paraventricular nucleus (PVN) and plasma adrenocorticotropin (ACTH) concentration were significantly higher; total corticosterone (B) plasma level was similar but free B level was lower; (ii) exposure to a novel environment resulted in a higher and prolonged plasma ACTH and total B response in the apo-sus rats. Moreover, the elevated free B level was also prolonged; (iii) apo-sus rats had increased CRH-induced pituitary ACTH release and B secretion was also increased, but not as prolonged as during novelty. (iv) In dexamethasone-pretreated rats an intravenous ACTH1-24 injection resulted in a similar plasma B response in rats of both lines; (v) In vitro, ACTH1-24 produced a significantly higher B secretion by adrenocortical cells of apo-sus rats reflecting the higher in vivo ACTH priming of the adrenal glands in these animals. (vi) apo-sus rats had higher body and thymic weight.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7767328     DOI: 10.1111/j.1365-2826.1995.tb00678.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  7 in total

1.  Apomorphine-susceptible and apomorphine-unsusceptible Wistar rats differ in their susceptibility to inflammatory and infectious diseases: a study on rats with group-specific differences in structure and reactivity of hypothalamic-pituitary-adrenal axis.

Authors:  A Kavelaars; C J Heijnen; B Ellenbroek; H van Loveren; A Cools
Journal:  J Neurosci       Date:  1997-04-01       Impact factor: 6.167

2.  Analysis of the biphasic locomotor response to ethanol in high and low responders to novelty: a study in Nijmegen Wistar rats.

Authors:  M A Gingras; A R Cools
Journal:  Psychopharmacology (Berl)       Date:  1996-06       Impact factor: 4.530

Review 3.  Brain-corticosteroid hormone dialogue: slow and persistent.

Authors:  E R de Kloet; N Y Rots; A R Cools
Journal:  Cell Mol Neurobiol       Date:  1996-06       Impact factor: 5.046

4.  The effect of 'two hit' neonatal and young-adult stress on dopaminergic modulation of prepulse inhibition and dopamine receptor density.

Authors:  Kwok Ho Christopher Choy; Yvonne P de Visser; Maarten van den Buuse
Journal:  Br J Pharmacol       Date:  2009-01-13       Impact factor: 8.739

5.  Maternal care affects the phenotype of a rat model for schizophrenia.

Authors:  Ruben W M van Vugt; Francisca Meyer; Josephus A van Hulten; Jeroen Vernooij; Alexander R Cools; Michel M M Verheij; Gerard J M Martens
Journal:  Front Behav Neurosci       Date:  2014-08-11       Impact factor: 3.558

6.  Individual differences in the sensitivity to serotonergic drugs: a pharmacobehavioural approach using rats selected on the basis of their response to novelty.

Authors:  Michel M M Verheij; Jesse V Veenvliet; Tom Groot Kormelink; Maaike Steenhof; Alexander R Cools
Journal:  Psychopharmacology (Berl)       Date:  2009-05-12       Impact factor: 4.530

7.  Identification of genetic and epigenetic variations in a rat model for neurodevelopmental disorders.

Authors:  Karen M J van Loo; Gerard J M Martens
Journal:  Behav Genet       Date:  2007-09       Impact factor: 2.805

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.